Table 3.
Association of clinicopathological factors with a 5-year survival rate.
| Clinicopathological factors | No. (%) | 5-year survival rate (%) | P value |
|---|---|---|---|
| Gender | 0.54 | ||
| Male | 122 (70.9) | 60 | |
| Female | 50 (29.1) | 54.9 | |
| Age | 0.95 | ||
| ≤60 | 98 (57.0) | 58.1 | |
| ≥60 | 74 (43.0) | 55.1 | |
| Tumor size (cm) | 0.01∗ | ||
| ≤2 | 31 (18.0) | 96.8 | |
| 2~5 | 79 (45.9) | 57 | |
| ≥5 | 62 (36.1) | 35.5 | |
| Tumor differentiation | 0.00∗ | ||
| High or moderate differentiation | 47 (27.3) | 87.5 | |
| Low differentiation | 125 (72.7) | 47 | |
| Level 2 LNMM | 0.01∗ | ||
| Positive | 72 (41.9) | 42 | |
| Negative | 100 (58.1) | 76.4 | |
| The depth of tumor invasion | 0.01∗ | ||
| T1 | 19 (11.1) | 86.1 | |
| T2 | 26 (15.1) | 72.3 | |
| T3 | 101 (58.7) | 56.4 | |
| T4 | 26 (15.1) | 27.8 | |
| Operation mode | 0.07∗ | ||
| Total gastrectomy | 119 (69.2) | 59.9 | |
| Distal gastrectomy | 53 (30.8) | 37.5 | |
| Neural invasion | 0.42 | ||
| Yes | 37 (21.5) | 51.4 | |
| No | 135 (78.5) | 57.8 | |
| Lauren classification | 0.01∗ | ||
| Diffusive type | 104 (60.5) | 48.1 | |
| Intestinal type | 68 (39.5) | 69.1 | |
| TNM staging | 0.01∗ | ||
| IA | 19 (11.1) | 86.1 | |
| IB | 26 (15.1) | 72.3 | |
| IIA | 101 (58.8) | 56.4 | |
| IIB | 19 (11.1) | 30.1 | |
| III | 7 (9.9) | 21.8 | |
| Lymphatic infiltration | 0.01∗ | ||
| Yes | 96 (55.8) | 43.8 | |
| No | 76 (44.2) | 72.4 |
LNMM: lymph node micrometastasis; TNM: tumor node metastasis; ∗P < 0.05.